KR101090102B1 - 벤조옥사졸 설폰아미드 화합물 및 그의 중간체를 제조하는방법 - Google Patents
벤조옥사졸 설폰아미드 화합물 및 그의 중간체를 제조하는방법 Download PDFInfo
- Publication number
- KR101090102B1 KR101090102B1 KR1020067005992A KR20067005992A KR101090102B1 KR 101090102 B1 KR101090102 B1 KR 101090102B1 KR 1020067005992 A KR1020067005992 A KR 1020067005992A KR 20067005992 A KR20067005992 A KR 20067005992A KR 101090102 B1 KR101090102 B1 KR 101090102B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- amino
- alkyl
- het
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 CC1(C=C2OC(N(*)*)=NC2=CC=C1)S(N(*)CC(C(*)N(*)*)O)(=O)=O Chemical compound CC1(C=C2OC(N(*)*)=NC2=CC=C1)S(N(*)CC(C(*)N(*)*)O)(=O)=O 0.000 description 7
- FLFWJIBUZQARMD-UHFFFAOYSA-N Sc1nc2ccccc2[o]1 Chemical compound Sc1nc2ccccc2[o]1 FLFWJIBUZQARMD-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03103630.4 | 2003-09-30 | ||
| EP03103630 | 2003-09-30 | ||
| US50799603P | 2003-10-02 | 2003-10-02 | |
| US60/507,996 | 2003-10-02 | ||
| PCT/EP2004/052382 WO2005030739A1 (en) | 2003-09-30 | 2004-09-30 | Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20060092224A KR20060092224A (ko) | 2006-08-22 |
| KR101090102B1 true KR101090102B1 (ko) | 2011-12-07 |
Family
ID=34395298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020067005992A Expired - Fee Related KR101090102B1 (ko) | 2003-09-30 | 2004-09-30 | 벤조옥사졸 설폰아미드 화합물 및 그의 중간체를 제조하는방법 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20070123574A1 (https=) |
| EP (1) | EP1670773B1 (https=) |
| JP (1) | JP4919802B2 (https=) |
| KR (1) | KR101090102B1 (https=) |
| CN (1) | CN1860107B (https=) |
| AP (1) | AP1985A (https=) |
| AT (1) | ATE353323T1 (https=) |
| AU (1) | AU2004276017B2 (https=) |
| BR (1) | BRPI0414916A (https=) |
| CA (1) | CA2537877C (https=) |
| DE (1) | DE602004004674T2 (https=) |
| DK (1) | DK1670773T3 (https=) |
| EA (1) | EA011891B1 (https=) |
| ES (1) | ES2281828T3 (https=) |
| IL (1) | IL173891A0 (https=) |
| IN (1) | IN2012DN02301A (https=) |
| MX (1) | MXPA06003575A (https=) |
| NO (1) | NO20061951L (https=) |
| NZ (1) | NZ546279A (https=) |
| PL (1) | PL1670773T3 (https=) |
| PT (1) | PT1670773E (https=) |
| SI (1) | SI1670773T1 (https=) |
| WO (1) | WO2005030739A1 (https=) |
| ZA (1) | ZA200602603B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR053845A1 (es) * | 2005-04-15 | 2007-05-23 | Tibotec Pharm Ltd | 5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450 |
| US8575186B2 (en) | 2009-10-05 | 2013-11-05 | Albany Molecular Research, Inc. | Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereof |
| AU2012207335A1 (en) | 2011-01-19 | 2013-07-25 | Albany Molecular Research, Inc. | Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia |
| WO2014194519A1 (en) | 2013-06-07 | 2014-12-11 | Merck Sharp & Dohme Corp. | Imidazole derivatives and methods of use thereof for improving pharmacokinetics of drug |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002083657A2 (en) * | 2001-02-14 | 2002-10-24 | Tibotec Pharmaceuticals Ltd. | Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968942A (en) * | 1992-08-25 | 1999-10-19 | G. D. Searle & Co. | α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| CN1530372A (zh) * | 1995-03-10 | 2004-09-22 | G.D.ɪ����˾ | 杂环羰基氨基酸羟乙氨基磺酰胺逆转录病毒蛋白酶抑制剂 |
| AU7722296A (en) * | 1995-11-15 | 1997-06-05 | G.D. Searle & Co. | Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| EP1208092B1 (en) * | 2000-04-07 | 2006-06-21 | Samsung Electronics Co., Ltd. | Sulfonamide derivative as a matrix metalloproteinase inhibitor |
| US6455738B1 (en) * | 2000-07-13 | 2002-09-24 | Rhodia Chimie | Process for the sulfonation of an aromatic compound |
| EA009590B1 (ru) * | 2001-05-11 | 2008-02-28 | Тиботек Фармасьютикалз Лтд. | 2-аминобензоксазолсульфонамидные ингибиторы вич-протеазы широкого спектра |
| TWI286476B (en) * | 2001-12-12 | 2007-09-11 | Tibotec Pharm Ltd | Combination of cytochrome P450 dependent protease inhibitors |
| MY142238A (en) * | 2002-03-12 | 2010-11-15 | Tibotec Pharm Ltd | Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors |
-
2004
- 2004-09-30 JP JP2006530265A patent/JP4919802B2/ja not_active Expired - Fee Related
- 2004-09-30 AU AU2004276017A patent/AU2004276017B2/en not_active Ceased
- 2004-09-30 BR BRPI0414916-5A patent/BRPI0414916A/pt not_active IP Right Cessation
- 2004-09-30 KR KR1020067005992A patent/KR101090102B1/ko not_active Expired - Fee Related
- 2004-09-30 ES ES04766869T patent/ES2281828T3/es not_active Expired - Lifetime
- 2004-09-30 AT AT04766869T patent/ATE353323T1/de active
- 2004-09-30 NZ NZ546279A patent/NZ546279A/en not_active IP Right Cessation
- 2004-09-30 WO PCT/EP2004/052382 patent/WO2005030739A1/en not_active Ceased
- 2004-09-30 AP AP2006003603A patent/AP1985A/xx active
- 2004-09-30 CN CN2004800280971A patent/CN1860107B/zh not_active Expired - Fee Related
- 2004-09-30 IN IN2301DEN2012 patent/IN2012DN02301A/en unknown
- 2004-09-30 CA CA2537877A patent/CA2537877C/en not_active Expired - Fee Related
- 2004-09-30 MX MXPA06003575A patent/MXPA06003575A/es active IP Right Grant
- 2004-09-30 EP EP04766869A patent/EP1670773B1/en not_active Expired - Lifetime
- 2004-09-30 DK DK04766869T patent/DK1670773T3/da active
- 2004-09-30 PT PT04766869T patent/PT1670773E/pt unknown
- 2004-09-30 SI SI200430265T patent/SI1670773T1/sl unknown
- 2004-09-30 PL PL04766869T patent/PL1670773T3/pl unknown
- 2004-09-30 US US10/574,157 patent/US20070123574A1/en not_active Abandoned
- 2004-09-30 EA EA200600699A patent/EA011891B1/ru not_active IP Right Cessation
- 2004-09-30 DE DE602004004674T patent/DE602004004674T2/de not_active Expired - Lifetime
-
2006
- 2006-02-22 IL IL173891A patent/IL173891A0/en not_active IP Right Cessation
- 2006-03-29 ZA ZA200602603A patent/ZA200602603B/xx unknown
- 2006-05-02 NO NO20061951A patent/NO20061951L/no not_active Application Discontinuation
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002083657A2 (en) * | 2001-02-14 | 2002-10-24 | Tibotec Pharmaceuticals Ltd. | Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1670773A1 (en) | 2006-06-21 |
| CN1860107B (zh) | 2013-08-21 |
| DE602004004674T2 (de) | 2007-11-22 |
| AU2004276017A1 (en) | 2005-04-07 |
| PT1670773E (pt) | 2007-05-31 |
| CA2537877C (en) | 2015-03-17 |
| DE602004004674D1 (de) | 2007-03-22 |
| AU2004276017B2 (en) | 2010-08-19 |
| NZ546279A (en) | 2008-09-26 |
| EA011891B1 (ru) | 2009-06-30 |
| ZA200602603B (en) | 2008-05-28 |
| IL173891A0 (en) | 2006-07-05 |
| ES2281828T3 (es) | 2007-10-01 |
| JP4919802B2 (ja) | 2012-04-18 |
| EA200600699A1 (ru) | 2006-08-25 |
| BRPI0414916A (pt) | 2006-11-07 |
| MXPA06003575A (es) | 2006-06-05 |
| CA2537877A1 (en) | 2005-04-07 |
| AP1985A (en) | 2009-03-30 |
| WO2005030739A1 (en) | 2005-04-07 |
| AP2006003603A0 (en) | 2006-04-30 |
| JP2007507468A (ja) | 2007-03-29 |
| NO20061951L (no) | 2006-05-02 |
| CN1860107A (zh) | 2006-11-08 |
| IN2012DN02301A (https=) | 2015-08-14 |
| SI1670773T1 (sl) | 2007-06-30 |
| EP1670773B1 (en) | 2007-02-07 |
| KR20060092224A (ko) | 2006-08-22 |
| PL1670773T3 (pl) | 2007-06-29 |
| DK1670773T3 (da) | 2007-05-29 |
| ATE353323T1 (de) | 2007-02-15 |
| US20070123574A1 (en) | 2007-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4818124B2 (ja) | （３Ｒ，３ａＳ，６ａＲ）−ヘキサヒドロフロ〔２，３−ｂ〕フラン−３−イル（１Ｓ，１Ｒ）−３−〔〔（４−アミノフェニル）スルホニル〕（イソブチル）アミノ〕−１−ベンジル−２−ヒドロキシプロピルカルバマートの製造方法 | |
| KR100870184B1 (ko) | 광범위 2-(치환된-아미노)-벤조티아졸 설폰아미드 ｈｉｖ프로티아제 억제제 | |
| US20040039016A1 (en) | HIV protease inhibitors | |
| KR101192859B1 (ko) | （3ｒ,3ａｓ,6ａｒ）-헥사하이드로푸로〔2,3-ｂ〕푸란-3-일（1ｓ,2ｒ）-3-〔〔（4-아미노페닐）설포닐〕（이소부틸）아미노〕-1-벤질-2-하이드록시프로필카바메이트의 제조방법 | |
| ES2519115T3 (es) | Procedimiento para la preparación de (1S,2R)-3-[[(4-aminofenil)sulfonil](isobutil)amino]-1-bencil-2-hidroxipopilcarbamato de (3R,3aS,6aR)-hexahidrofuro[2,3-b]furan-3-ilo | |
| KR101090102B1 (ko) | 벤조옥사졸 설폰아미드 화합물 및 그의 중간체를 제조하는방법 | |
| KR100942743B1 (ko) | 광범위 스펙트럼 헤테로사이클릭 치환된 페닐 포함설폰아미드 ｈｉｖ 프로테아제 저해제 | |
| EP1485358A1 (en) | Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| R15-X000 | Change to inventor requested |
St.27 status event code: A-3-3-R10-R15-oth-X000 |
|
| R16-X000 | Change to inventor recorded |
St.27 status event code: A-3-3-R10-R16-oth-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| A201 | Request for examination | ||
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-3-3-R10-R13-asn-PN2301 St.27 status event code: A-3-3-R10-R11-asn-PN2301 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U12-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-5-5-R10-R13-asn-PN2301 St.27 status event code: A-5-5-R10-R11-asn-PN2301 |
|
| FPAY | Annual fee payment |
Payment date: 20141031 Year of fee payment: 4 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4 |
|
| LAPS | Lapse due to unpaid annual fee | ||
| PC1903 | Unpaid annual fee |
St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 20151201 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20151201 |